Written answers

Tuesday, 26 March 2019

Department of Health

Medicinal Products Reimbursement

Photo of Tommy BroughanTommy Broughan (Dublin Bay North, Independent)
Link to this: Individually | In context | Oireachtas source

853. To ask the Minister for Health if patient advocacy groups will be included in the terms of reference for the mini-review by his Department of the drugs approval process here; and if he will make a statement on the matter. [13700/19]

Photo of Michael Healy-RaeMichael Healy-Rae (Kerry, Independent)
Link to this: Individually | In context | Oireachtas source

929. To ask the Minister for Health if patient groups (details supplied) will be included in the review of the drug approval process here; and if he will make a statement on the matter. [14108/19]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 853 and 929 together.

My Department has completed a tender process for a review of the HSE reimbursement and pricing decision-making process and are currently appointing a consultancy firm to complete this review.

Although patients groups were not included in the terms of reference, consideration will be given to consultation with relevant stakeholders.

Comments

No comments

Log in or join to post a public comment.